Researcher develops living tissue to study birth defects

A new approach to studying tissue development could yield insight into orthopedic birth defects that occur in utero.

By TUFTS UNIVERSITY
November 12, 2011 02:11
2 minute read.
Biomedical engineer Catherine K. Kuo in the lab

Catherine K. Kuo Lab engineer 311. (photo credit: Kelvin Ma/Tufts University)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

MEDFORD/SOMERVILLE, Mass. – A new approach to studying tissue development has earned Catherine K. Kuo, Ph.D., an assistant professor of biomedical engineering in Tufts University's School of Engineering, the Basil O'Connor Starter Scholar Award from the March of Dimes Foundation.

Kuo's research could yield insight into factors that contribute to orthopedic birth defects that occur in utero, such as clubfoot, which requires multiple surgeries to enable normal standing and walking. These defects occur as a result of abnormal musculoskeletal tissue development of the embryo.

Be the first to know - Join our Facebook page.


In her experiments, Kuo will use living engineered embryonic tendon tissue to see how muscle movement by the developing fetus—for example, kicking—might influence abnormal musculoskeletal tissue development in the embryo.

"Currently we don't know the extent to which muscle activity contributes to birth defects," says Kuo. "I chose the tendon as a model tissue to study because of its critical roles in force transmission and joint stabilization in a normal musculoskeletal system."

Kuo will engineer tendon tissue in the lab from cells from chick and mouse embryos. "It's very difficult to study developing tissue, in this case, tendon, inside the body, and especially in utero," she says.

Kuo will seed living embryonic cells into a porous, biodegradable synthetic scaffold. Placed into a nutrient-rich bioreactor, the cell-seeded scaffold will grow into living engineered tissue.

Kuo will subject the tissue-engineered tendon to forces that mimic muscle movement, such as flexing, which occurs during kicking. Using this approach, Kuo will study what happens when cells are forming into tendons while being constantly exposed to stretching, twisting, and other forces.

JPOST VIDEOS THAT MIGHT INTEREST YOU:


"At the end of the day, we want to have the answers to the questions: How does tissue stiffness affect the developing cells? How does movement such as kicking affect them? And what are the combined effects of stiffness and movement?" says Kuo.

In addition, Kuo plans to intentionally engineer a developing tissue with abnormal stiffness to investigate its effect on embryonic development. These studies could potentially lead to learning which interventions could restore normal functioning after birth.

"By engineering and testing normally and abnormally developing tissues in the lab, we can perform large, systematic studies to screen the effects of different therapies that we couldn’t easily do otherwise," she says.

Among her research goals is to discover if she can "retrain" embryonic or fetal cells. "During embryonic development, could we treat the cells and tissues in utero, or could we even take them out, treat them in a bioreactor to recondition them to behave normally, and then put them back in and help develop the normal function of that tissue?" she asks.

The Basil O'Connor Starter Scholar Research Award, $150,000 over two years, is designed to support young scientists and engineers embarking on their research careers with a particular focus on the prevention or treatment of birth defects.

This article was first published at www.newswise.com.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

Lab
August 31, 2014
Weizmann scientists bring nature back to artificially selected lab mice

By JUDY SIEGEL-ITZKOVICH